Phase Ib/II study of safety and efficacy of low ‐dose decitabine‐primed chemoimmunotherapy in patients with drug‐resistant relapsed/refractory alimentary tract cancer

International Journal of Cancer, EarlyView.

Source: International Journal of Cancer - April 26, 2018 Category: Cancer & Oncology Authors: MeixiaChen , JingNie , YangLiu , XiangLi , YanZhang , Malcolm V.Brock , KaichaoFeng , ZhiqiangWu , XiaoleiLi , LuShi , SuxiaLi , MingzhouGuo , QianMei , WeidongHan Source Type: research